Page last updated: 2024-10-30

labetalol and Amphetamine Abuse

labetalol has been researched along with Amphetamine Abuse in 2 studies

Labetalol: A salicylamide derivative that is a non-cardioselective blocker of BETA-ADRENERGIC RECEPTORS and ALPHA-1 ADRENERGIC RECEPTORS.
labetalol : A diastereoisomeric mixture of approximately equal amounts of all four possible stereoisomers ((R,S)-labetolol, (S,R)-labetolol, (S,S)-labetalol and (R,R)-labetalol). It is an adrenergic antagonist used to treat high blood pressure.
2-hydroxy-5-{1-hydroxy-2-[(4-phenylbutan-2-yl)amino]ethyl}benzamide : A member of the class of benzamides that is benzamide substituted by a hydroxy group at position 2 and by a 1-hydroxy-2-[(4-phenylbutan-2-yl)amino]ethyl group at position 5.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Richards, JR1
Lange, RA1
Arnold, TC1
Horowitz, BZ1
DueƱas-Garcia, OF1

Other Studies

2 other studies available for labetalol and Amphetamine Abuse

ArticleYear
Dual cocaine and methamphetamine cardiovascular toxicity: rapid resolution with labetalol.
    The American journal of emergency medicine, 2017, Volume: 35, Issue:3

    Topics: Administration, Intravenous; Adrenergic beta-Antagonists; Amphetamine-Related Disorders; Anti-Anxiet

2017
False-positive amphetamine toxicology screen results in three pregnant women using labetalol.
    Obstetrics and gynecology, 2011, Volume: 118, Issue:2 Pt 1

    Topics: Amphetamine; Amphetamine-Related Disorders; Antihypertensive Agents; False Positive Reactions; Femal

2011